Co-Authors
This is a "connection" page, showing publications co-authored by Nuofu Zhang and Nanshan Zhong.
Connection Strength
1.658
-
Effect of Recombinant Human Granulocyte Colony-Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia: A Randomized Clinical Trial. JAMA Intern Med. 2021 01 01; 181(1):71-78.
Score: 0.230
-
Symptomless multi-variable apnea prediction index assesses adverse outcomes in patients with Corona Virus Disease 2019. Sleep Med. 2020 11; 75:294-300.
Score: 0.225
-
Improved night shift schedule related to the mortality of critically ill patients with Corona Virus Disease 2019. Sleep Med. 2020 11; 75:354-360.
Score: 0.224
-
Secondary infection in severe and critical COVID-19 patients in China: a multicenter retrospective study. Ann Palliat Med. 2021 Aug; 10(8):8557-8570.
Score: 0.060
-
Bufei huoxue capsules in the management of convalescent COVID-19 infection: study protocol for a multicenter, double-blind, and randomized controlled trial. Pulm Circ. 2021 Jul-Sep; 11(3):20458940211032125.
Score: 0.060
-
Earlier diagnosis improves COVID-19 prognosis: a nationwide retrospective cohort analysis. Ann Transl Med. 2021 Jun; 9(11):941.
Score: 0.059
-
Predictors of fatal outcomes among hospitalized COVID-19 patients with pre-existing hypertension in China. Clin Respir J. 2021 Aug; 15(8):915-924.
Score: 0.059
-
Addendum: Early triage of critically ill COVID-19 patients using deep learning. Nat Commun. 2021 02 01; 12(1):826.
Score: 0.058
-
Clinical application of an intelligent oropharyngeal swab robot: implication for the COVID-19 pandemic. Eur Respir J. 2020 Aug; 56(2).
Score: 0.056
-
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19. JAMA Intern Med. 2020 08 01; 180(8):1081-1089.
Score: 0.056
-
Early triage of critically ill COVID-19 patients using deep learning. Nat Commun. 2020 07 15; 11(1):3543.
Score: 0.056
-
Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China. Eur Respir J. 2020 06; 55(6).
Score: 0.055
-
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020 05; 55(5).
Score: 0.055
-
Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol. 2020 Jul; 146(1):89-100.
Score: 0.055
-
Clinical characteristics of COVID-19 infection in chronic obstructive pulmonary disease: a multicenter, retrospective, observational study. J Thorac Dis. 2020 May; 12(5):1811-1823.
Score: 0.055
-
Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China. Chest. 2020 07; 158(1):97-105.
Score: 0.055
-
Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. Lancet Haematol. 2020 05; 7(5):e362-e363.
Score: 0.055
-
Clinical application of invasive cardiopulmonary exercise test for dyspnea diagnosis in Chinese people. J Thorac Dis. 2018 Nov; 10(Suppl 33):S4176-S4178.
Score: 0.050
-
Pulmonary Capillary Hemangiomatosis without Pulmonary Hypertension: An Early Stage of Disease? Chin Med J (Engl). 2018 Jan 20; 131(2):245-246.
Score: 0.047
-
Optical coherence tomography in imaging of peripheral pulmonary arteries. J Thorac Dis. 2017 Jul; 9(7):1937-1944.
Score: 0.045
-
Comparison of rivaroxaban mono-therapy and standard-therapy adjusted by CYP2C9 and VKORC1 genotypes in symptomatic pulmonary embolism. Clin Chim Acta. 2016 Aug 01; 459:25-29.
Score: 0.042